Velan Capital Investment Management LP's Q4 2023 13F: 5 new positions, 13 exits

Form 13F-HR for the quarter ended Dec 31, 2023 · filed Feb 14, 2024 · 19 reported positions · accession 0001848809-24-000005

What changed this quarter

Velan Capital Investment Management LP's changes in reported equity positions, Q4 2023
Activity Security Weight before Weight now Change Shares Shares %
New TOURMALINE BIO INC (TRML) — 5.9% +5.9 pts +319K sh new
Exited QUIPT HOME MEDICAL CORP (QIPT) 4.6% — −4.6 pts −1.1M sh −100%
New ROIVANT SCIENCES LTD (ROIV) — 4.0% +4.0 pts +500K sh new
Reduced TELA BIO INC (TELA) 4.9% 0.4% −4.5 pts −669K sh −90%
Exited MOONLAKE IMMUNOTHERAPEUTICS (MLTX) 2.6% — −2.6 pts −55,300 sh −100%
Exited GOSSAMER BIO INC (GOSS) 2.1% — −2.1 pts −3.07M sh −100%
Exited CABALETTA BIO INC (CABA) 1.9% — −1.9 pts −150K sh −100%
Exited TENET HEALTHCARE CORP (THC) 1.3% — −1.3 pts −24,937 sh −100%
New ACLARIS THERAPEUTICS INC (ACRS) — 1.3% +1.3 pts +1.76M sh new
Increased ADMA BIOLOGICS INC (ADMA) 5.1% 6.8% +1.8 pts +400K sh +23%
Exited ICOSAVAX INC (ICVX) 1.0% — −1.0 pts −161K sh −100%
Exited ASLAN PHARMACEUTICALS LTD (ASLN) 1.0% — −1.0 pts −625K sh −100%
Exited ANNEXON INC (ANNX) 0.9% — −0.9 pts −460K sh −100%
New IMMUNOVANT INC (IMVT) — 0.8% +0.8 pts +27,500 sh new
Exited EDESA BIOTECH INC (EDSA) 0.7% — −0.7 pts −1.28M sh −100%
New ENVVENO MEDICAL CORPORATION (NVNO) — 0.6% +0.6 pts +172K sh new
Exited CULLINAN ONCOLOGY INC (CGEM) 0.6% — −0.6 pts −75,000 sh −100%
Exited INFLARX NV (IFRX) 0.5% — −0.5 pts −200K sh −100%
Exited REZOLUTE INC (RZLT) 0.4% — −0.4 pts −400K sh −100%
Increased INSPIRE MED SYS INC (INSP) 2.5% 2.6% +0.1 pts +2,700 sh +18%
Exited INHIBRX INC (INBX) 0.4% — −0.4 pts −25,000 sh −100%
Increased OPTINOSE INC (OPTN) 3.6% 3.5% −0.1 pts +200K sh +6%

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

† Security identifier (CUSIP) changed — read as one continuing position, not an exit and a new position:

  • PRAXIS PRECISION MEDICINES I (PRAX): 74006W108 → 74006W207, 5.19M → 346K shares (share count change consistent with a stock split)

Top 10 positions — 89.0% of the equity book

Changes in the top 10 this quarter: TRML entered · IMGN entered · ROIV entered · TELA left · QIPT left · MLTX left

# Security Weight before Weight now
1 ALIMERA SCIENCES INC (ALIM) 34.5% 41.6%
2 HERON THERAPEUTICS INC (HRTX) 5.9% 8.4%
3 ADMA BIOLOGICS INC (ADMA) 5.1% 6.8%
4 JASPER THERAPEUTICS INC (JSPR) 6.2% 6.1%
5 TOURMALINE BIO INC (TRML) 0.0% 5.9% Entered the top 10
6 PRAXIS PRECISION MEDICINES I (PRAX) 7.2% 5.5%
7 IMMUNOGEN INC (IMGN) 2.5% 4.0% Entered the top 10
8 ROIVANT SCIENCES LTD (ROIV) 0.0% 4.0% Entered the top 10
9 OPTINOSE INC (OPTN) 3.6% 3.5%
10 LANTHEUS HLDGS INC (LNTH) 4.3% 3.3%
— TELA BIO INC (TELA) 4.9% 0.4% Left the top 10
— QUIPT HOME MEDICAL CORP (QIPT) 4.6% 0.0% Left the top 10
— MOONLAKE IMMUNOTHERAPEUTICS (MLTX) 2.6% 0.0% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).

Option positions (puts and calls)

Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.

Activity Security Type Shares before Shares now Reported value
New ISHARES TR (IWM) Put 0 150K $30.1M
Exited IOVANCE BIOTHERAPEUTICS INC (IOVA) Call 250K 0 $0
Exited QUIPT HOME MEDICAL CORP (QIPT) Call 100K 0 $0